In’Tech Medical, Inc., a company founded in France in 2000, has acquired Turner Medical, Inc., of Athens, Alabama, making the combined firm the world’s largest provider of surgical instruments to the spine industry and a world leader in orthopedic contract manufacturing.
World’s Largest Contract Spine Instrument Company Created

“In’Tech Medical is the number one contract-manufacturer in Europe, with a significant U.S. presence. The acquisition of Turner Medical further improves In’Tech Medical’s manufacturing expertise, expands its U.S. business, its global capacity, and adds the manufacturing of orthopedic implants to its core business.”
“In’Tech Medical’s demonstrated leadership in contract manufacturing and proprietary orthopedic instrument design is greatly enhanced with the addition of Turner Medical, ” said Laurent Pruvost, President of In’Tech Medical SAS. “What I most value is the unique talent that Turner Medical has developed over the past 35 years. The management’s know-how, combined with that of In’Tech Medical’s, turns the group into a creative engineering and problem solving powerhouse; a serious asset for our clients and a tangible competitive advantage.”
“At Turner Medical, we are all about customer satisfaction and family values, ” said company President Bill Turner. “The company was founded by my father John Turner in 1985. We took it from a local machine shop to a nationally-recognized organization with the highest quality standards, latest technologies, and most efficient processes. Merging with In’Tech Medical allows Turner Medical to further develop and provide the services that are most beneficial to our clients, both in the U.S. and internationally.”
According to the press release, In’Tech Medical’s 2015 consolidated sales forecast is $65 million, to be produced equally between Europe and the United States. The firm has close to 500 employees globally.

Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.